[1]
|
Loehrer Sr PJ, Feng Y, Cardenes H, et al. Gemcitabine alone versus gemcitabine plus radiotherapy in patients with locally advanced pancreatic cancer:an Eastern Cooperative Oncology Group trial[J]. J Clin Oncol, 2011, 29:4105-4112. http://jjco.oxfordjournals.org/cgi/ijlink?linkType=ABST&journalCode=jco&resid=29/31/4105 |
[2]
|
Bussels B, Goethals L, Feron M, et al. Respiration-induced movement of the upper abdominal organs:a pitfall for the three-dimensional conformal radiation treatment of pancreatic cancer[J]. Radiother Oncol, 2003, 68:69-74. http://www.sciencedirect.com/science/article/pii/S0167814003001336 |
[3]
|
Whitfield G, Jain P, Green M, et al. Quantifying motion for pancreatic radiotherapy margincal culation[J]. Radiother Oncol, 2012, 103:360-366. http://search.ebscohost.com/login.aspx?direct=true&db=aph&AN=76305905&site=ehost-live |
[4]
|
Huguet F, Goodman KA, Azria D, et al. Radiotherapy technical considerations in the management of locally advanced pancreatic cancer:American-French consensus recommendations[J]. Int J Radiat Oncol Biol Phys, 2012, 83:1355-1364. http://www.ncbi.nlm.nih.gov/pubmed/22768988 |
[5]
|
Khashab MA, Kim KJ, Tryggestad EJ, et al. Comparative analysis of traditional andcoiled fiducials implanted during EUS for pancreatic cancer patients receiving gstereotactic body radiation therapy[J].Gastrointest Endosc, 2012, 76:962-971. http://www.sciencedirect.com/science/article/pii/S0016510712024728 |
[6]
|
Brown MW, Ning H, Arora B, et al. A dosimetric analysis of dose escalation using two intensity-modulated radiation therapy techniques in locally advanced pancreatic carcinoma[J]. Int J Radiat Oncol Biol Phys, 2006, 65:274-283. http://www.wanfangdata.com.cn/details/detail.do?_type=perio&id=aa82819c9b7f0fc4f83e624947671288 |
[7]
|
胡克, 侯晓荣, 张福泉, 等.胰腺癌精确放疗的疗效及预后分析[J].协和医学杂志, 2013, 4:371-376. http://d.wanfangdata.com.cn/Periodical/xhyx201304006 |
[8]
|
Yovino S, Poppe M, Jabbour S, et al. Intensity-modulated radiation therapy significantly improves acute gastrointestinal toxicity inpancreatic and ampullary cancers[J].Int J Radiat Oncol Biol Phys, 2011, 79:158-162. http://www.sciencedirect.com/science/article/pii/S036030160903510X |
[9]
|
Yovino S, Maidment BW 3rd, Herman JM, et al. Analysis of local control in patients receiving IMRT for resected pancreatic cancers[J]. Int J Radiat Oncol Biol Phys, 2012, 83:916-920. http://www.wanfangdata.com.cn/details/detail.do?_type=perio&id=055464085b01f663fb98cee039457321 |
[10]
|
Koong AC, Le QT, Ho A, et al. phase Ⅰ study of stereotactic radiosurgery in patients with locally advanced pancreatic cancer[J]. Int J Radiat Oncol Biol Phys, 2004, 58:1017-1021. http://www.ncbi.nlm.nih.gov/pubmed/15001240 |
[11]
|
Koong AC, Christofferson E, Le QT, et al. phase Ⅱ study to assess the efficacy of conventionally fractionated radiotherapy followed by astereotactic radiosurgery boost in patients with locally advanced pancreatic cancer[J]. Int J Radiat Oncol Biol Phys, 2005, 63:320-323. http://www.ncbi.nlm.nih.gov/pubmed/16168826 |
[12]
|
Schellenberg D, Goodman KA, Lee F, et al. Gemcitabine chemotherapy and single-fraction stereotactic body radiotherapy for locally advanced pancreatic cancer[J]. Int J Radiat Oncol Biol Phys, 2008, 72:678-686. http://www.ncbi.nlm.nih.gov/pubmed/18395362 |
[13]
|
Pollom EL, Alagappan M, von Eyben R, et al. Single-versus multifraction sterotactic body radiation therapy for pancreatic adenocarcinoma:outcomes and toxicity[J]. Int J Radiat Oncol Biol Phys, 2014, 90:918-925. http://www.sciencedirect.com/science/article/pii/S0360301614034579 |
[14]
|
Chuong MD, Springett GM, Freilich JM, et al. Stereotactic body radiation therapy for locally advanced and borderline resectable pancreatic cancer is effective and well tolerated[J]. Int J Radiat Oncol Biol Phys, 2013, 86:516-522. http://www.wanfangdata.com.cn/details/detail.do?_type=perio&id=9cacbded2a6850f4a7fad15dbf126fb8 |
[15]
|
Murphy JD, Christman-Skieller C, Kim J, et al. A dosimetric model of duodenal toxicity after stereotactic body radiotherapy for pancreatic cancer[J]. Int J Radiat Oncol Biol Phys, 2010, 78:1420-1426. http://www.wanfangdata.com.cn/details/detail.do?_type=perio&id=1f56d504cf62c489a735156899a1573e |
[16]
|
Alfieri S, Morganti AG, Di Giorgio A, et al. Improved survival and local control after intraoperative radiation therapy and postoperative radiotherapy:a multivariate analysis of 46 patients undergoing surgery for pancreatic head cancer[J].Arch Surg, 2001, 136:343-347. http://www.onacademic.com/detail/journal_1000039818700310_0e25.html |
[17]
|
Reni M, Panucci MG, Ferreri AJ, et al. Effect on local control and survival of electron beam intraoperative irradiation for resectable pancreatic adenocarcinoma[J]. Int J Radiat Oncol Biol Phys, 2001, 50:651. http://www.wanfangdata.com.cn/details/detail.do?_type=perio&id=25384424597cd3612756bdfb323c7c4a |
[18]
|
Ogawa K, Karasawa K, Ito Y, et al. Intraoperative radiotherapy for resected pancreatic cancer:a multi-institutional retrospective analysis of 210 patients[J]. Int J Radiat Oncol Biol Phys, 2010, 77:734-742. |
[19]
|
Valentini V, Calvo F, Reni M, et al. Intra-operative radiotherapy (IORT) in pancreatic cancer:joint analysis of the ISIORT-Europe experience[J]. Radiother Oncol, 2009, 91:54-59. http://www.sciencedirect.com/science/article/pii/S0167814008003770 |
[20]
|
Shibamoto Y, Manabe T, Ohshio G, et al. High-dose intra-operative radiotherapy for unresectable pancreatic cancer[J]. Int J Radiat Oncol Biol Phys, 1996, 34:57-63. http://www.researchgate.net/publication/11259444_High-dose_intraoperative_radiotherapy_for_unresectable_pancreatic_cancer |
[21]
|
Tepper JE, Noyes D, Krall JM, et al. Intraoperative radiation therapy of pancreatic carcinoma:a report of RTOG-8505. Radiation Therapy Oncology Group[J]. Int J Radiat Oncol Biol Phys, 1991, 21:1145-1149. |
[22]
|
Schuricht AL, Spitz F, Barbot D, et al. Intraoperative radiotherapy in the combined-modality management of pancreatic cancer[J]. Am Surg, 1998, 64:1043-1049. http://www.ncbi.nlm.nih.gov/pubmed/9798766 |